Reducing agent and tunicamycin-responsive protein (RTP) mRNA expression in the placentae of normal and pre-eclamptic women

Placenta

Volumn 25, Issue 1, 2004, Pages 62-69

  Gratton, R J ^a   Gluszynski, M ^a   Nygard, K ^a   Mazzuca, D M ^a   Graham, C H ^b   Han, V K M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLACENTA PROTEIN; REDUCING AGENT; TUNICAMYCIN RESPONSIVE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CHORION VILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; HYPOXIA; OXYGEN TENSION; PERFUSION; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STRESS; SYNCYTIOTROPHOBLAST; TROPHOBLAST; UPREGULATION;

EID: 0345874707     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(03)00216-9     Document Type: Article

References (24)

1. Kokame K, Kato H, Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. J Biol Chem 1996;271:29659-65.
2. van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made A, Nozawa Y et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 1997;77:85-92.
3. Park H, Adams MA, Lachat P, Bosman F, Pang SC, Graham CH. Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 2000; 276:321-8.
4. Xu B, Lin L, Rote NS. Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis. Biol Reprod 1999;61:681-6.
5. Brosens IA, Robertson WB, Dixon HG. The role of spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177-91.
6. Khong TY, DeWolf F, Robertson WB, Bronsens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-59.
7. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeclampsic pregnancies. Br J Obstet Gynaecol 1994; 101:669-74.
8. Redman CW. Current Topic: pre-eclampsia and the placenta. Placenta 1991;12:304-10.
9. Zhou Y, Damsky CH, Chui K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive trophoblasts. J Clin Invest 1993;91:950-60.
10. Genbacev O, Joslin R, Damsky CH, Pillotti BM, Fisher SJ. Hypoxia alters early gestation human trophoblast differentiation/ invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996;97:540-51.
11. ACOG Technical Bulletin. Hypertension in pregnancy. ACOG Technical Bulletin 219. Washington, DC, 1996.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:150-9.
13. Delhanty PJD, Han VKM. The expression of insulin-like growth factor (IGF) binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus. Endocrinology 1993;132:41-52.
14. Han VKM, Bassett N, Walton J, Challis JRG. The expression of insulin-like growth factor (IGF) and IGF binding protein (IGFBP) genes in the human placenta and membranes: Evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 1996; 81:2680-93.
15. Chappell LC, Seed PT, Briley AL et al. Effect of antioxidants on the occurence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999;354:810-6.
16. Tominaga T, Page EW. Accommodation of the human placenta to hypoxia. Am J Obstet Gynecol 1966;84:679-91.
17. Benirschke K, Kaufmann P. Pathology of the human placenta. 3rd ed New York: Springer-Verlag, 1996.
18. Fox H. Histologic abnormalities of the placenta. In: Fox H., editor. Pathology of the placenta. London: W.B. Saunders; 1997.
19. Henriksen T. The role of lipid peroxidation and oxidative lipid derivatives in the development of preeclampsia. Semin Perinatol 2000; 24:29-32.
20. Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998;179:1605-11.
21. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol 2000;96:271-6.
22. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001;184:1249-50.
23. Huppertz B, Frank HG, Kingdom JCP, Reister F, Kaufmann. Villous cytotrophoblasts regulation of the synetial apoptotic cascade in the human placenta. Histochem Cell Biol 1998;110:495-508.
24. Gratton RJ, Asano H, Han VKM. IGF-II and IGFBP-1 mRNA expression in the placenta of women with preeclampsia. Placenta 2001 submitted.